HIV taken by STORM: Super-resolution fluorescence microscopy of a viral infection
- Cândida F Pereira†2, 3, 4,
- Jérémie Rossy†1,
- Dylan M Owen1,
- Johnson Mak2, 5, 6Email author and
- Katharina Gaus1Email author
© Pereira et al.; licensee BioMed Central Ltd. 2012
Received: 9 November 2011
Accepted: 2 May 2012
Published: 2 May 2012
The visualization of viral proteins has been hindered by the resolution limit of conventional fluorescent microscopes, as the dimension of any single fluorescent signal is often greater than most virion particles. Super-resolution microscopy has the potential to unveil the distribution of proteins at the resolution approaching electron microscopy without relying on morphological features of existing characteristics of the biological specimen that are needed in EM.
Using direct stochastic optical reconstruction microscopy (dSTORM) to achieve a lateral resolution of 15–20 nm, we quantified the 2-D molecular distribution of the major structural proteins of the infectious human immunodeficiency virus type 1 (HIV-1) before and after infection of lymphoid cells. We determined that the HIV-1 matrix and capsid proteins undergo restructuring soon after HIV-1 infection.
This study provides the proof-of-concept for the use of dSTORM to visualize the changes in the molecular distribution of viral proteins during an infection.
KeywordsHIV Super-resolution microscopy Electron microscopy Viruses Dynamic movement Protein rearrangement
The human immunodeficiency virus type 1 (HIV-1) is approximately spherical with a mean diameter of 125 ± 14 nm [1–3]. Its main structural components are a lipid bilayer containing envelope glycoproteins, a matrix shell located beneath the viral lipid membrane and a capsid core with a cone shaped geometry [1–3]. After fusion of HIV-1 with the target cell, it is postulated that the matrix shell is retained at the plasma membrane while the capsid core undergoes a dramatic disassembly process that facilitates the reverse transcription of the viral genome [3–5]. Fluorescent labeling of HIV-1 proteins has provided valuable insights into their sub-cellular localization in infected cells [6, 7]. However, the molecular mechanisms of cell entry and replication are difficult to detect since the viral particle is smaller than the resolution limit of conventional fluorescent microscopes. Electron microscopy techniques have provided structural insights of HIV-1 [1, 2, 7] but remain technically demanding and are prone to introduce artifacts.
The development of far-field super-resolution light microscopy methods such as stochastic optical reconstruction microscopy (STORM)  and photoactivatable localization microscopy (PALM)  enable the localization of individual photoswitchable protein-labeled molecules with a spatial resolution of tens of nanometers. The more recently developed direct STORM (dSTORM) combines standard immunocytochemistry, total internal reflection fluorescence (TIRF) microscopy and reversible photoswitching of conventional organic fluorochromes such as Cy5 and Alexa 647 to further improve the quality of signals . This technique has a tremendous potential for the visualization of the molecular organization of viral proteins during an infection, particularly if tagging with fluorescent proteins compromises virus infectivity. Previously studies have used super-resolution techniques to visualize clusters of viral proteins artificially transfected into cell lines [11–13]. In this study we have used dSTORM to provide one of the first the molecular distribution of matrix and capsid proteins in infectious HIV-1 particles before and after a real infection of lymphoid cells.
Results and discussion
To quantify the distribution and heterogeneity of viral proteins, we used a variation on Ripley’s K- function analysis . As shown for the matrix protein in cell-free HIV-1 (Figure 2e-h), the single molecule dSTORM image was converted into a pseudo-colored cluster map that is based on the number of other molecules within a 50 nm radius, normalized to the overall particle density (Figure 2f). The contours describing each cluster were extracted and the number of clusters and cluster sizes determined (Figure 2g). To identify the replicating viruses that are travelling to the nucleus we used the GFP-Vpr fusion protein, which is incorporated into the virus particles and remains associated with the replicating viruses during intracellular trafficking . GFP-Vpr was therefore used to identify ‘double positive’ viral protein clusters that were associated with the viral replication machinery and contained the matrix or capsid protein (Figure 2h).
This analysis allowed us to accurately measure the sizes of matrix and capsid protein clusters co-localized with GFP-Vpr in cell-free virons and in infected cells (Figure 2i). In cell-free virions, the size of the matrix protein clusters are within the expected range of 106–183 nm  and, as expected, the size of the capsid protein clusters are significantly smaller than the matrix protein clusters (p < 0.0001, Figure 2i). Twenty minutes post infection of T lymphocytes, the matrix protein clusters and the capsid protein clusters were similar in size (Figure 2i), which indicates that upon infection the capsid protein clusters showed a significantly large fractional increase in size (236%) when compared with the matrix protein clusters. This single molecule imaging approach hence allowed us to follow the restructuring of the matrix shell and capsid core during infection, which may reflect the structural rearrangements that facilitate the HIV-1 reverse transcription process, such as virion uncoating.
We were able to quantify the size of the HIV-1 matrix shell and capsid core by dSTORM and these results were in agreement with the known HIV organization seen by EM [1, 2, 17]. Furthermore, this approach provided new information showing that upon cell entry, the size of the virion matrix shell and capsid core increased significantly when compared to cell-free HIV-1 virions, which indicates that the HIV particles underwent a dramatic rearrangement immediately after entry into the target cell. In summary, this study validates the use of dSTORM to assess the molecular distribution of viral proteins during the life-cycle of an infectious virus, and it opens up new possibilities to study the distribution and re-distribution of viral proteins at the early phase of viral infection.
Cells and virus
MT-2 cells (obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH from D. Richman) [18, 19] were cultured in Rosewell Park Memorial Institute (RPMI) 1640 medium (Invitrogen) supplemented with 10% vol/vol heat-inactivated fetal calf serum (FCS; Invitrogen, Mount Waverley, Victoria, Australia) and penicillin/streptomycin. 293 T cells were maintained in Dulbecco’s modified Eagle medium/high modified (with 4500 mg/l dextrose and 4 mM L-glutamine) medium (DMEM; Invitrogen), supplemented with 10% (vol/vol) heat-inactivated cosmic calf serum (CCS; Hyclone, Tauranga, New Zealand), 100 U/ml of penicillin and 100 mg/ml of streptomycin (Invitrogen).
The pNL4-3 proviral DNA (obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH from M. Martin ) contains the NL4-3 infectious molecular clone of HIV-1. The pNL4-3Δenv proviral DNA (obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH from N. Landau [21, 22]) contains an envelope defective-pNL4-3 molecular clone of HIV-1. HIV-1 particles were produced by poly(ethylenimine) (PEI; Polysciences Inc., Warrington, PA, USA) transfection of 293 T cells with pNL4-3 or pNL4-3Δenv proviral DNA and GFP-Vpr plasmid (kindly provided by T. Hope, Northwestern University) to generate GFP-Vpr-labeled HIV-1 (HIVGFP-Vpror HIVΔenvGFP-Vpr). Forty hours post-transfection viral particles were purified, concentrated and quantified as previously described . Briefly, supernatant from 293 T cells was filtered and viral particles were concentrated by ultracentrifugation through a 20% sucrose cushion at 100,000 x g for 1 h at 4°C using an L-90 ultracentrifuge (SW 41 rotor; Beckman, Fullerton, CA, USA) and virus pellets were resuspended in 1x phosphate buffered saline (PBS; Invitrogen) and quantified using a HIV-1 antigen (p24 CA) micro enzyme-linked immunosorbent assay (ELISA) (Vironostika: Biomerieux, Boxtel, The Netherlands).
Infection of lymphoid cells
Synchronized infections were performed as described previously . Briefly, MT-2 cells were infected with HIVGFP-Vpr (normalized to 1000 ng of p24 per million cells) by spinoculation at 17°C for 2 h at 1,200 x g. Afterwards, the cells were washed twice with PBS to remove unbound virus and incubated with warm media at 37°C, 5% CO2 for 20 min to initiate infection. Afterwards, the cells were washed, treated with 2 mg/ml of protease from Streptomyces griseus (pronase E; Sigma-Aldrich, Castle Hill, NSW, Australia) for 10 min on ice and washed extensively with PBS containing 20% FCS. The cells were then fixed with 4% formaldehyde (Polysciences) in 0.1 M pipes buffer, pH 6.8, washed with PBS and cytospined onto glass coverslips. Cell-free viruses (same batch as used for the infection of lymphoid cells) were also fixed with formaldehyde in pipes buffer, evenly spread on glass slides to achieve optimal sample thickness, incubated at 4°C for 16 h and washed twice with PBS.
Cells and virus were permeabilized and stained with mouse anti-matrix (SVM-33) antibody (MH-SVM33C9, ATCC, Manassas, VA (Akzo Nobel N.V.) or mouse anti-capsid (AG3.0) antibody (obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH from J. Allan)  and goat Cy5-conjugated anti-mouse secondary antibody (Jackson ImmunoResearch, USA).
Image acquisition and analysis
Antibody stained cells were imaged in an oxygen scavenging buffer (50 μ g/ml glucose oxidase, 25 μ g/ml horseradish peroxidase, 75 mM β-mercaptoethylamine, 25 mM Hepes, 25 mM glucose, 5% glycerol in PBS, pH 8) in an open Chamlide™ chamber (Live Cell Instrument, Seoul, Korea). Cells were imaged with surface-immobilized 100 nm colloidal gold beads (BBInternational, Cardiff, UK) that allow correction for sample drift during the acquisition.
dSTORM images were acquired on a prototype PALM microscope (Carl Zeiss GmbH, Jena, Germany) with TIRF illumination. In dSTORM, the carbocyanine dye Cy5 is stochastically converted to a long-lived dark state (‘off’) when excited using 633 nm (15 mW) laser radiation and switched back ‘on’ by exposure to low intensities of 488 nm (0.1–1 mW) laser light when the sample is immersed in a oxygen depleted buffer containing a reducing agent . By adjusting the intensity of the 488 nm laser, the density of fluoroescent molecules was approximately kept constant during acquisition and across samples. Images of 5–6 cells per sample from two different experiments were captured using an Andor iXon DU-897D EMCCD camera (Andor Technology Plc, Belfast, UK), giving a pixel size of 100 nm at the sample plane.
dSTORM images were reconstructed from a series of 20,000 TIRF images using Zeiss Zen software. Molecular clustering was analyzed using Getis and Franklins 2nd order analysis as previously described . Localization precision corresponds to one sigma of the Gaussian distribution of the point spread function that is fitted to individual molecules and is also affected by photons and noise level . Data was cropped so as to exclude points with localization precision worse than 50 nm. A 10 × 10 μm region is then selected for analysis and rendered into cluster maps with 7 nm/pixel resolution. Cluster maps were threshold to create a binary map from which only clusters that significantly overlapped with a TIRF image of GFP-Vpr were selected and analyzed using ImageJ .
Pronase treatment efficiency
MT-2 cells were infected with HIVGFP-Vpr or HIVΔenvGFP-Vpr as described above and afterwards the samples were split. Half of the cells were treated with pronase to remove non-internalized virus as described above and half of the cells were incubated with PBS. The cells were then cytospined onto glass slides, counterstained with Hoechst 33258 (Invitrogen), mounted in Fluoromount-G (Electron Microscopy Sciences, Hatfield, PA) and images were captured in a z series on a charge-coupled device (CCD) camera (CoolSnap HQ; Photometrics, Tucson, AZ) through a 100 × 1.4 numerical aperture (NA) oil immersion lens on a DeltaVision microscope (Applied Precision, Issaquah, WA) and deconvolved using softWoRx deconvolution software (Applied Precision).
Data derived from the diameter of 26–173 molecular clusters per sample was analyzed by paired two-tailed Student’s t test. A p value < 0.001 was considered highly statistically significant for all tests.
CFP carried out the virus components of this study in the Mak lab (JM) at Burnet Institute; JR and DMO conducted the dSTORM imaging and analyses in the Gaus lab (KG) at UNSW. All authors contributed to the design, data interpretation and writing of the manuscript. All authors read and approved the final manuscript.
We acknowledge the financial support from the National Health and Medical Research Council of Australia (C.F.P., J.M., K.G.), the Australian Research Council (K.G., D.O., J.M.), Human Frontier Science Pro- gram (K.G.), the European Social Fund of the European Commission (C.F.P.) and the Portuguese Foundation for Science and Technology (C.F.P.). J.M. is a recipient of the Pfizer Foundation Fellowship and ARC Future Fellowship. We thank T. Hope for the GFP-Vpr plasmid and S. Turville for the MH-SVM33C9 purified hybridoma supernatant.
- Briggs JA, Grunewald K, Glass B, Forster F, Krausslich HG, Fuller SD: The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure 2006, 14: 15-20. 10.1016/j.str.2005.09.010PubMedView Article
- Goto T, Nakai M, Ikuta K: The life-cycle of human immunodeficiency virus type 1. Micron 1998, 29: 123-138. 10.1016/S0968-4328(98)00002-XPubMedView Article
- Miller MD, Farnet CM, Bushman FD: Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol 1997, 71: 5382-5390.PubMedPubMed Central
- Karageorgos L, Li P, Burrell C: Characterization of HIV replication complexes early after cell-to-cell infection. AIDS Res Hum Retroviruses 1993, 9: 817-823. 10.1089/aid.1993.9.817PubMedView Article
- Yamashita M, Perez O, Hope TJ, Emerman M: Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog 2007, 3: 1502-1510.PubMedView Article
- Arhel N, Genovesio A, Kim KA, Miko S, Perret E, Olivo-Marin JC, Shorte S, Charneau P: Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes. Nat Methods 2006, 3: 817-824. 10.1038/nmeth928PubMedView Article
- McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, Emerman M, Hope TJ: Visualization of the intracellular behavior of HIV in living cells. J Cell Biol 2002, 159: 441-452. 10.1083/jcb.200203150PubMedPubMed CentralView Article
- Rust MJ, Bates M, Zhuang X: Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM). Nat Methods 2006, 3: 793-795. 10.1038/nmeth929PubMedPubMed CentralView Article
- Betzig E, Patterson GH, Sougrat R, Lindwasser OW, Olenych S, Bonifacino JS, Davidson MW, Lippincott-Schwartz J, Hess HF: Imaging intracellular fluorescent proteins at nanometer resolution. Science 2006, 313: 1642-1645. 10.1126/science.1127344PubMedView Article
- Heilemann M, van de Linde S, Schuttpelz M, Kasper R, Seefeldt B, Mukherjee A, Tinnefeld P, Sauer M: Subdiffraction-resolution fluorescence imaging with conventional fluorescent probes. Angew Chem Int Ed Engl 2008, 47: 6172-6176. 10.1002/anie.200802376PubMedView Article
- Hess ST, Gould TJ, Gudheti MV, Maas SA, Mills KD, Zimmerberg J: Dynamic clustered distribution of hemagglutinin resolved at 40 nm in living cell membranes discriminates between raft theories. Proc Natl Acad Sci U S A 2007, 104: 17370-17375. 10.1073/pnas.0708066104PubMedPubMed CentralView Article
- Eckhardt M, Anders M, Muranyi W, Heilemann M, Krijnse-Locker J, Muller B: A SNAP-tagged derivative of HIV-1–a versatile tool to study virus-cell interactions. PLoS One 2011, 6: e22007. 10.1371/journal.pone.0022007PubMedPubMed CentralView Article
- Lehmann M, Rocha S, Mangeat B, Blanchet F, Uji IH, Hofkens J, Piguet V: Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction. PLoS Pathog 2011, 7: e1002456. 10.1371/journal.ppat.1002456PubMedPubMed CentralView Article
- Pereira CF, Ellenberg PC, Jones KL, Fernandez TL, Smyth RP, Hawkes DJ, Hijnen M, Vivet-Boudou V, Marquet R, Johnson I, Mak J: Labeling of multiple HIV-1 proteins with the biarsenical-tetracysteine system. PLoS One 2011, 6: e17016. 10.1371/journal.pone.0017016PubMedPubMed CentralView Article
- Williamson DJ, Owen DM, Rossy J, Magenau A, Wehrmann M, Gooding JJ, Gaus K: Pre-existing clusters of the adaptor Lat do not participate in early T cell signaling events. Nat Immunol 2011, 12: 655-662. 10.1038/ni.2049PubMedView Article
- Owen DM, Rentero C, Rossy J, Magenau A, Williamson D, Rodriguez M, Gaus K: PALM imaging and cluster analysis of protein heterogeneity at the cell surface. J Biophotonics 2010, 3: 446-454. 10.1002/jbio.200900089PubMedView Article
- Welker R, Hohenberg H, Tessmer U, Huckhagel C, Krausslich HG: Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J Virol 2000, 74: 1168-1177. 10.1128/JVI.74.3.1168-1177.2000PubMedPubMed CentralView Article
- Harada S, Koyanagi Y, Yamamoto N: Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 1985, 229: 563-566. 10.1126/science.2992081PubMedView Article
- Haertle T, Carrera CJ, Wasson DB, Sowers LC, Richman DD, Carson DA: Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2′,3′-dideoxyadenosine derivatives. J Biol Chem 1988, 263: 5870-5875.PubMed
- Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986, 59: 284-291.PubMedPubMed Central
- He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR: Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995, 69: 6705-6711.PubMedPubMed Central
- Connor RI, Chen BK, Choe S, Landau NR: Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995, 206: 935-944. 10.1006/viro.1995.1016PubMedView Article
- O’Doherty U, Swiggard WJ, Malim MH: Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 2000, 74: 10074-10080. 10.1128/JVI.74.21.10074-10080.2000PubMedPubMed CentralView Article
- Simm M, Shahabuddin M, Chao W, Allan JS, Volsky DJ: Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J Virol 1995, 69: 4582-4586.PubMedPubMed Central
- Perry GLW: SpPack:spatial point pattern analysis in Excel using Visual Basic for Applications (VBA). Environ Model Softw 2004, 19: 559-569. 10.1016/j.envsoft.2003.07.004View Article
- Abramoff MD, Magelhaes PJ, Ram SJ: Image Processing with ImageJ. Biophotonics Int 2004, 11: 36-42.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.